Todd Watanabe
Chief Executive Officer at ARCUTIS BIOTHERAPEUTICS, INC.
Net worth: 9 M $ as of 2024-04-29
Todd Watanabe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 2015-12-31 | - |
| Chief Executive Officer | 2017-03-31 | - | |
| President | 2015-12-31 | - | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Director/Board Member | 2021-06-22 | - |
Career history of Todd Watanabe
Former positions of Todd Watanabe
| Companies | Position | Start | End |
|---|---|---|---|
| Kanan Therapeutics, Inc. | Chief Operating Officer | 2015-11-30 | 2018-01-31 |
| Founder | 2015-11-30 | 2018-01-31 | |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 2013-09-30 | 2015-10-31 |
Training of Todd Watanabe
| Georgetown University | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
| Kanan Therapeutics, Inc. | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
- Stock Market
- Insiders
- Todd Watanabe
- Experience